These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 8411650
1. [Rapid development of primary amyloidosis after two years' follow-up of monoclonal gammopathy of undetermined significance (MGUS)]. Kanoh T, Inoue M, Okuma M. Rinsho Ketsueki; 1993 Aug; 34(8):952-6. PubMed ID: 8411650 [Abstract] [Full Text] [Related]
2. [A long-term observation of development from monoclonal gammopathy of undetermined significance (MGUS) into primary amyloidosis]. Kanoh T, Yago K, Okuma M. Rinsho Ketsueki; 1990 Oct; 31(10):1740-4. PubMed ID: 2255066 [Abstract] [Full Text] [Related]
3. [Detection of monoclonal plasma cells in bone marrow and spleen of primary amyloidosis]. Katayama Y, Sakai A, Nobuyoshi M, Shimomura T, Kimura A. Rinsho Ketsueki; 2001 Sep; 42(9):705-9. PubMed ID: 11680983 [Abstract] [Full Text] [Related]
4. Malignant transformation in IgM monoclonal gammopathy of undetermined significance. Montoto S, Rozman M, Rosiñol L, Nadal E, Giné E, Aymerich M, Ferrer A, Esteve J, Bosch F, López-Guillermo A, Bladé J, Montserrat E. Semin Oncol; 2003 Apr; 30(2):178-81. PubMed ID: 12720132 [Abstract] [Full Text] [Related]
5. Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis. Rajkumar SV, Mesa RA, Fonseca R, Schroeder G, Plevak MF, Dispenzieri A, Lacy MQ, Lust JA, Witzig TE, Gertz MA, Kyle RA, Russell SJ, Greipp PR. Clin Cancer Res; 2002 Jul; 8(7):2210-6. PubMed ID: 12114422 [Abstract] [Full Text] [Related]
7. Should bone marrow examination be routinely performed for the diagnosis of monoclonal gammopathy of undetermined significance? Elis A, Radnay J, Shapiro H, Itzhaky D, Manor Y, Lishner M. Isr Med Assoc J; 2006 Dec 01; 8(12):840-2. PubMed ID: 17214099 [Abstract] [Full Text] [Related]
8. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, Melton LJ. N Engl J Med; 2002 Feb 21; 346(8):564-9. PubMed ID: 11856795 [Abstract] [Full Text] [Related]
9. [Primary amyloidosis associated with IgD-lambda M-proteinemia]. Kimura S, Iwatsuka R, Aoki T, Odawara J, Asada N, Yamakura M, Takeuchi M, Matsue K. Rinsho Ketsueki; 2007 Dec 21; 48(12):1555-8. PubMed ID: 18203516 [Abstract] [Full Text] [Related]
10. Lower bone mineral density in geriatric patients with monoclonal gammopathy of undetermined significance. Dizdar O, Erman M, Cankurtaran M, Halil M, Ulger Z, Yavuz BB, Ariogul S, Pinar A, Harputluoglu H, Kars A, Celik I. Ann Hematol; 2008 Jan 21; 87(1):57-60. PubMed ID: 17874101 [Abstract] [Full Text] [Related]
11. [More than 10 years of complete remission of monoclonal gammopathy of undetermined significance and cessation of light chain deposition disease-associated nephrotic syndrome following treatment with vincristine, adriamycin and high-dose dexamethasone (VAD)]. Adam Z, Nedbálková M, Krejcí M, Pour L, Husek K, Veselý K, Cermáková Z, Krivanová A, Mayer J, Hájek R. Vnitr Lek; 2010 Mar 21; 56(3):240-6. PubMed ID: 20394211 [Abstract] [Full Text] [Related]
12. [Study of monoclonal gammopathy in Kagawa Prefectural Central Hospital]. Uchida M, Taida N, Kanao M, Kagamihara H, Kuwajima M. Rinsho Byori; 2004 Jul 21; 52(7):574-9. PubMed ID: 15344556 [Abstract] [Full Text] [Related]
13. Neuropathies associated with IgG and IgA monoclonal gammopathy. Nobile-Orazio E, Casellato C, Di Troia A. Rev Neurol (Paris); 2002 Oct 21; 158(10 Pt 1):979-87. PubMed ID: 12407307 [Abstract] [Full Text] [Related]
14. Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece. Anagnostopoulos A, Evangelopoulou A, Sotou D, Gika D, Mitsibounas D, Dimopoulos MA. Ann Hematol; 2002 Jul 21; 81(7):357-61. PubMed ID: 12185503 [Abstract] [Full Text] [Related]
15. Monoclonal gammopathies of undetermined significance. Kyle RA, Rajkumar SV. Best Pract Res Clin Haematol; 2005 Jul 21; 18(4):689-707. PubMed ID: 16026745 [Abstract] [Full Text] [Related]
16. [Incidence, clinico-biological characteristics, and clinical course of 1,203 monoclonal gammopathies (1971-1992)]. Giraldo P, Rubio-Félix D, Cortés T, Delgado P, Franco E, Gimeno J, Tapia M, Giralt M. Sangre (Barc); 1994 Oct 21; 39(5):343-50. PubMed ID: 7754438 [Abstract] [Full Text] [Related]
17. [Benign monoclonal gammopathy]. Shirota T, Kondo M, Uchida H, Ito H. Nihon Rinsho; 1995 Mar 21; 53(3):720-4. PubMed ID: 7699912 [Abstract] [Full Text] [Related]
18. [Monoclonal gammopathy of undetermined significance]. Chaïbi P, Merlin L, Thomas C, Piette F. Ann Med Interne (Paris); 2002 Nov 21; 153(7):459-66. PubMed ID: 12598832 [Abstract] [Full Text] [Related]
19. [Multiple myeloma after monoclonal gammopathy of uncertain significance. Study of 10 patients]. Salgado C, Bladé J, López-Guillermo A, Cervantes F, Montserrat E, Rozman C. Sangre (Barc); 1993 Oct 21; 38(5):371-4. PubMed ID: 8140498 [Abstract] [Full Text] [Related]
20. [Polyneuropathy and monoclonal IgG/IgA gammopathy--differential neurography on the basis of two patient cases]. Abler B, Gdynia HJ, von Arnim CA. Fortschr Neurol Psychiatr; 2009 Feb 21; 77(2):105-9. PubMed ID: 19221974 [Abstract] [Full Text] [Related] Page: [Next] [New Search]